Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - fulvestrant - תמיסה להזרקה - fulvestrant 250 mg / 5 ml - fulvestrant - fulvestrant - faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - zolmitriptan - טבליות מצופות פילם - zolmitriptan 2.5 mg - zolmitriptan - zolmitriptan - acute treatment of migraine with or without aura.

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - budesonide - אבקה לשאיפה - budesonide 200 mcg/dose - budesonide - budesonide - bronchial asthma.

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - budesonide - אבקה לשאיפה - budesonide 100 mcg/dose - budesonide - budesonide - bronchial asthma.

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - budesonide - תרחיף לשאיפה - budesonide 0.25 mg/ml - budesonide - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - budesonide - תרחיף לשאיפה - budesonide 0.5 mg/ml - budesonide - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - ticagrelor - טבליות מצופות פילם - ticagrelor 60 mg - ticagrelor

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - osimertinib as mesylate - טבליה - osimertinib as mesylate 40 mg - osimertinib

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - osimertinib as mesylate - טבליה - osimertinib as mesylate 80 mg - osimertinib

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - quetiapine as fumarate - טבליות בשחרור ממושך - quetiapine as fumarate 150 mg - quetiapine